H
MRNA icon

HoyleCohen’s Moderna MRNA Stock Holding History

HoyleCohen’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,474
Closed -$226K – 264
2023
Q1 		$226K Hold
1,474
– – 0.02% 240
2022
Q4 		$265K Buy
+1,474
New +$241K 0.03% 233
2022
Q3 		– Sell
-1,474
Closed -$211K – 262
2022
Q2 		$211K Hold
1,474
– – 0.02% 243
2022
Q1 		$254K Sell
1,474
-1
-0.1% -$168 0.02% 239
2021
Q4 		$375K Buy
1,475
+381
+35% +$111K 0.03% 215
2021
Q3 		$421K Sell
1,094
-110
-9% -$40.6K 0.04% 193
2021
Q2 		$283 Buy
+1,204
New +$215K 0.02% 226

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HoyleCohen's MRNA Position: Q2 2023 in Review

HoyleCohen sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,474 shares — an estimated $226K sold.

HoyleCohen first reported a position in MRNA in Q2 2021 and held it in 7 quarters. The position peaked at $421K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • HoyleCohen reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • HoyleCohen sold 1,474 Moderna shares in Q2 2023, an estimated $226K.
  • HoyleCohen first reported a position in Moderna in Q2 2021 and held it in 7 quarters.
  • HoyleCohen's Moderna position peaked at $421K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on HoyleCohen's 13F filing for Q2 2023, filed 7 Aug 2023.